HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jon A Kobashigawa Selected Research

Heart Transplantation (Grafting, Heart)

4/2022Cardiac microstructural alterations in immune-inflammatory myocardial disease: a retrospective case-control study.
1/2022Heart transplant recipient 1-year outcomes during the COVID-19 pandemic.
1/2022Heart transplantation in muscular dystrophy: Single-center analysis.
1/2022Ex vivo normothermic perfusion in heart transplantation: a review of the TransMedics® Organ Care System.
11/2021Advanced heart failure and heart transplantation in adult congenital heart disease in the current era.
1/2021Heart transplant in Jehovah's Witness patients: A case-control study.
1/2021Intermediate-term outcomes of heart transplantation for cardiac amyloidosis in the current era.
10/2019Updates on Heart Transplantation.
9/2019Clinical Outcomes of Impella Microaxial Devices Used to Salvage Cardiogenic Shock as a Bridge to Durable Circulatory Support or Cardiac Transplantation.
10/2018Imaging in Heart Transplant Patients.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Jon A Kobashigawa Research Topics

Disease

20Heart Failure
02/2022 - 03/2004
12Cardiovascular Diseases (Cardiovascular Disease)
01/2022 - 01/2005
10Heart Diseases (Heart Disease)
01/2022 - 11/2002
8Coronary Artery Disease (Coronary Atherosclerosis)
01/2018 - 11/2004
6Infections
04/2022 - 12/2007
6Primary Graft Dysfunction
01/2022 - 11/2011
4Cardiomyopathies (Cardiomyopathy)
10/2019 - 10/2013
4Hypertension (High Blood Pressure)
01/2018 - 09/2006
3Myocarditis (Carditis)
04/2022 - 07/2002
3Amyloidosis
04/2022 - 10/2019
3Neoplasms (Cancer)
07/2020 - 07/2006
3Cardiogenic Shock
09/2019 - 11/2011
3Inflammation (Inflammations)
01/2018 - 04/2006
3Dyslipidemias (Dyslipidemia)
01/2018 - 01/2007
3Pathologic Constriction (Stenosis)
07/2017 - 04/2006
3Heart Arrest (Cardiac Arrest)
11/2011 - 04/2009
3Hyperplasia
01/2007 - 04/2006
2Frailty
01/2022 - 01/2020
2Fibrosis (Cirrhosis)
01/2021 - 12/2018
2Immunoglobulin Light-chain Amyloidosis
01/2021 - 01/2017
2Death (Near-Death Experience)
01/2018 - 09/2006
2Vasoplegia
01/2018 - 01/2017
1Aortic Valve Stenosis (Aortic Stenosis)
04/2022
1ST Elevation Myocardial Infarction
04/2022
1Chest Pain (Chest Pains)
04/2022
1Muscular Dystrophies (Muscular Dystrophy)
01/2022
1COVID-19
01/2022
1Congenital Heart Defects (Congenital Heart Defect)
11/2021
1Restrictive Cardiomyopathy
01/2021
1Shock
09/2019
1Renal Insufficiency (Renal Failure)
01/2019
1Vascular Diseases (Vascular Disease)
01/2018
1Diabetes Mellitus
01/2018
1Chagas Cardiomyopathy
08/2016
1Upper Extremity Deep Vein Thrombosis
07/2015
1Pulmonary Embolism
07/2015
1Venous Thrombosis (Deep-Vein Thrombosis)
07/2015
1Chagas Disease (American Trypanosomiasis)
10/2014
1Persistent Infection
10/2014
1Stroke (Strokes)
07/2014
1Atypical Hemolytic Uremic Syndrome
06/2014

Drug/Important Bio-Agent (IBA)

9omega-Chloroacetophenone (Mace)IBA
01/2022 - 09/2006
4Biomarkers (Surrogate Marker)IBA
12/2018 - 01/2005
4Phenobarbital (Luminal)FDA Link
01/2007 - 05/2005
3Amyloid (Amyloid Fibrils)IBA
01/2021 - 01/2017
3Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
07/2020 - 07/2004
3CreatinineIBA
01/2018 - 04/2006
3Cyclosporine (Ciclosporin)FDA LinkGeneric
12/2013 - 01/2007
3Tacrolimus (Prograf)FDA LinkGeneric
12/2013 - 01/2007
3thiazole-4-carboxamide adenine dinucleotide (TCAD)IBA
07/2006 - 04/2006
2Prostaglandins DIBA
01/2022 - 01/2021
2Brain Natriuretic Peptide (Natrecor)FDA Link
12/2018 - 12/2013
2LipidsIBA
01/2013 - 04/2006
2EverolimusFDA Link
12/2007 - 07/2006
2Pharmaceutical PreparationsIBA
03/2007 - 01/2007
1Hemoglobins (Hemoglobin)IBA
01/2021
1Intravenous Immunoglobulins (IVIG)FDA Link
07/2020
1Immune Checkpoint InhibitorsIBA
07/2020
1CalciumIBA
01/2020
1Proteins (Proteins, Gene)FDA Link
01/2020
1Amyloidogenic ProteinsIBA
10/2019
1trichrome stainIBA
12/2018
1EnzymesIBA
12/2018
1pro-brain natriuretic peptide (1-76)IBA
12/2018
1dicarboxydine (DCD)IBA
01/2018
1Medical MarijuanaIBA
01/2016
1Anti-Bacterial Agents (Antibiotics)IBA
01/2016
1Anti-Arrhythmia AgentsIBA
10/2015
1p38 Mitogen-Activated Protein KinasesIBA
12/2013
1AntioxidantsIBA
12/2013
1C-Reactive ProteinIBA
12/2013
1Fibrinogen (Factor I)FDA Link
12/2013
1Glutathione (Reduced Glutathione)IBA
12/2013
1Phosphotransferases (Kinase)IBA
12/2013
1Cell Adhesion MoleculesIBA
12/2013
1Interleukin-6 (Interleukin 6)IBA
12/2013
1Thiobarbituric Acid Reactive SubstancesIBA
12/2013
1Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA
12/2013

Therapy/Procedure

44Heart Transplantation (Grafting, Heart)
04/2022 - 11/2002
10Transplantation
01/2022 - 07/2002
9Therapeutics
07/2020 - 07/2002
5Length of Stay
01/2022 - 01/2017
3Liver Transplantation
02/2022 - 01/2018
3Extracorporeal Membrane Oxygenation
09/2019 - 11/2011
2Contraindications
01/2022 - 02/2016
2Kidney Transplantation
01/2020 - 01/2019
2Cardiopulmonary Resuscitation (CPR)
09/2019 - 11/2011
2Cardiopulmonary Bypass (Heart-Lung Bypass)
01/2018 - 01/2017
2Organ Transplantation
10/2014 - 07/2006
1Mechanical Ventilators (Ventilator)
09/2019
1Continuous Renal Replacement Therapy
09/2019
1Renal Replacement Therapy (Therapies, Renal Replacement)
11/2018
1Anesthesia
01/2018
1Critical Care (Surgical Intensive Care)
01/2018
1Lung Transplantation
01/2018
1Stents
07/2017
1Drug Therapy (Chemotherapy)
01/2017
1Artificial Respiration (Mechanical Ventilation)
01/2017
1Artificial Heart (Artificial Hearts)
01/2017
1Highly Active Antiretroviral Therapy (HAART)
02/2016